Codes / ICD10CM / T36.6X3D

T36.6X3D Poisoning by rifampicins, assault, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by rifampicins, assault, subsequent encounter

Summary

This condition describes poisoning by rifampicins resulting from an assault, with the encounter classified as subsequent. It includes cases where intentional exposure to rifampicins leads to harmful effects due to an assault. Documentation should specify the assault-related nature of the exposure and encounter details to guide accurate coding.

Causes

Poisoning may result from deliberate exposure to rifampicins as part of an assault. This can occur due to forced ingestion, injection, or other intentional administration of the drug by another party. Adverse effects may stem from toxic reactions or cumulative toxicity at supratherapeutic doses.

Risk Factors

  • Exposure to situations involving interpersonal violence or assault.
  • Lack of control over medication administration during the event.
  • Prior history of conflict or violence increasing assault risk.
  • Environmental factors contributing to intentional harm by others.

Symptoms

  • Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea.
  • Hepatic: Jaundice, hepatotoxicity, elevated liver enzymes.
  • Systemic: Fever, hypotension, or organ dysfunction.
  • Neurological: Dizziness, confusion, or seizures in severe cases.
  • Allergic: Rash, urticaria, or anaphylaxis.

Diagnosis

Evaluation includes patient history of assault-related rifampicin exposure, clinical assessment of symptoms, and laboratory tests to confirm toxicity. Documentation should detail the circumstances of the exposure and any associated injuries.

Treatment Options

Management focuses on stabilizing the patient, removing unabsorbed drug, and providing supportive care. Specific treatments may include activated charcoal, antidotes if available, and monitoring for organ dysfunction. Psychological support may also be necessary.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of treatment, and severity of symptoms. Follow-up care should address both physical recovery and any psychological impact of the assault. Ongoing monitoring for delayed complications may be required.

Complications

  • Severe hepatotoxicity or liver failure.
  • Organ dysfunction from systemic toxicity.
  • Long-term psychological effects related to the assault.
  • Allergic reactions or anaphylaxis.

Lifestyle & Prevention

Prevention involves avoiding high-risk situations and ensuring safe environments. For individuals at risk, education on recognizing and reporting assault-related exposures may be beneficial. Support systems and security measures can reduce vulnerability.

When to Seek Professional Help

Seek immediate medical attention if exposure to rifampicins is suspected due to an assault, especially with symptoms like vomiting, abdominal pain, or altered consciousness. Prompt care is critical to minimize harm.

Tips for Medical Coders

Document the assault-related nature of the poisoning and specify the subsequent encounter. Ensure details about the exposure circumstances and clinical findings are clearly recorded to support accurate coding.

Book a walkthrough

T36.6X3D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.